Headquartered in Lincoln, Nebraska, Adjuvance is a privately held clinical-stage biopharmaceutical company. We are driven by a mission to empower health through fundamental advances in adjuvant design, vaccine development, and manufacturing. Our team of scientists, researchers and clinicians have developed the ability to synthesize next generation saponin adjuvants and are using them as the basis of developing new combination adjuvants and new adjuvanted vaccines.